Market Place
Sourcing Support
Corcept Gets Complete Response Letter For Relacorilant
01 Jan 2026 //
BUSINESSWIRE
NPPA Awaits Recovery Of 85% Overcharged Amount
31 Dec 2025 //
PHARMABIZ
TN DCA Reveals 364 Safety Violations as Coldrif Survivor Returns
31 Dec 2025 //
PHARMABIZ
UK Regulator Warns of Risky Online Treatments
31 Dec 2025 //
INDPHARMAPOST
Government Bans Nimesulide Oral Formulations Above 100 mg
31 Dec 2025 //
ECONOMICTIMES
Doctors Warn Against Antibiotic Misuse As Resistance Threat Grows
29 Dec 2025 //
ECONOMICTIMES
NPPA Permits Serum Institute To Halt Production Of 2 TT Vaccine
29 Dec 2025 //
PHARMABIZ
IIL Confirms Removal Of Counterfeit Abhayrab Rabies Vaccine
27 Dec 2025 //
ECONOMICTIMES
Drug Firms Extend GMP Compliance Time, States IDMA
27 Dec 2025 //
ECONOMICTIMES
Sun Pharma Arm Recalls 17K+ Antifungal Shampoos in US
25 Dec 2025 //
ECONOMICTIMES
Panel Urges Stringent Penalties For False Ayush Ads
24 Dec 2025 //
PHARMABIZ
CDSCO Reports 205 Samples As NSQ In November
23 Dec 2025 //
PHARMABIZ
TGA Seeks Feedback On Medicine Label Changes In Australia
22 Dec 2025 //
RAPS
Shape Memory Medical Obtains EU MDR Certification For IMPEDE
22 Dec 2025 //
BUSINESSWIRE
FDA Posts Warning Letters To Manufacturers Of Breast Binders
19 Dec 2025 //
RAPS
Minnesota Jury Awards $65.5M vs. Johnson & Johnson
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
AZ To Pull Bleeding Reversal Agent After FDA Flags Risk Imbalance
19 Dec 2025 //
FIERCE PHARMA
FDA hit Catalent`s Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
AKCDA Urges DCGI Action On Kerala Discount Pharmacies` Fake Drug
17 Dec 2025 //
PHARMABIZ
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Trial By Fire: Over 60% Of Pharma SMEs May Be Forced To Shut Shop
16 Dec 2025 //
ECONOMICTIMES
US FDA sends warning letters to Walmart
15 Dec 2025 //
REUTERS
Himachal Drug Cos Under Stop Orders Found Operational
13 Dec 2025 //
ECONOMICTIMES
GAO Finds FDA Staffing Shortfalls Delaying Device Recall Work
12 Dec 2025 //
FIERCE BIOTECH
AICDF Seeks Pharma Prosecution for Decade-Long Non-Compliance
11 Dec 2025 //
PHARMABIZ
FDA Warns Companies For CGMP Violations, Unapproved Marketing
10 Dec 2025 //
RAPS
Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA
09 Dec 2025 //
FIERCE PHARMA
India Pharma Inc Shifts From Compliance To Commitment In Safety
09 Dec 2025 //
EXPRESSPHARMA
FDA Panel Votes Against J&J Shunt Implant For Heart Failure
05 Dec 2025 //
FIERCE BIOTECH
USFDA Issues Form 483 With 3 Observations To Ipca`s Tarapur Plant
05 Dec 2025 //
ECONOMICTIMES
Precipio Identifies Unauthorized Access to Isolated Storage
04 Dec 2025 //
GLOBENEWSWIRE
FDA Official: CDER Warning Letters Up 50% In FY 2025
04 Dec 2025 //
RAPS
DOJ, FDA Prosecutions Highlight HCG Sales Risks
04 Dec 2025 //
PR NEWSWIRE
Bihar IPA Criticizes Regulatory Failure As DEG Syrup Kills 23
04 Dec 2025 //
PHARMABIZ
FDA Letter To Daiichi Takes Aim At Turalio Patient Video
04 Dec 2025 //
FIERCE PHARMA
Indonesia Firm Executive Suspect in Radioactive Contamination
04 Dec 2025 //
REUTERS
Ethiopian Team Visits Telangana for Drug Regulation Study
28 Nov 2025 //
PHARMABIZ
Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund
28 Nov 2025 //
ECONOMICTIMES
FDA Grants VAI Status to Biocon`s Bengaluru Facility
27 Nov 2025 //
ECONOMICTIMES
CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs
27 Nov 2025 //
BUSINESS STD
Glenmark Pharma Gets VAI From FDA For Monroe Facility
27 Nov 2025 //
INDPHARMAPOST
CDSCO Panel Calls For Consistent Drug Standard Enforcement
27 Nov 2025 //
BUSINESS STD
Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting
26 Nov 2025 //
PHARMABIZ
Sanofi Caught Up In Tax Fraud Probe Involving Several Companies
26 Nov 2025 //
FIERCE PHARMA
Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight
25 Nov 2025 //
PHARMABIZ
Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety
25 Nov 2025 //
INDPHARMAPOST
Commenters Advocate For Clearer Safety Label Guidance
24 Nov 2025 //
RAPS
Lupin Gets 7 Observations From USFDA For Goa Facility
24 Nov 2025 //
INDPHARMAPOST
CDSCO Reports Highest Number Of NSQs In 2025 In October
24 Nov 2025 //
PHARMABIZ
Shilpa Medicare Gets 8 Observations From FDA For Jadcherla Unit 4
24 Nov 2025 //
INDPHARMAPOST
Abbott To Replace CGMs After Incorrect Readings, Death Reports
24 Nov 2025 //
FIERCE BIOTECH
Solara`s Mangalore Facility Clears FDA Inspection With VAI Status
23 Nov 2025 //
INDPHARMAPOST
CDSCO Identifies 211 Drug Samples As NSQs, 5 As Spurious
22 Nov 2025 //
PHARMABIZ
NATCO API unit gets 7 observations from FDA Read more
22 Nov 2025 //
ET PHARMA
AIOCD Asks Traders To Strictly Comply With The Ban On 35 Fdcs
21 Nov 2025 //
PHARMABIZ
NABL Sets Terms For Labs To Obtain And Keep Accreditation
21 Nov 2025 //
PHARMABIZ
Piramal Pharma Solutions` UK Site Secures Renewed MHRA GMP
21 Nov 2025 //
INDPHARMAPOST
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Takeda`s Adzynma draws FDA scrutiny after paediatric death
21 Nov 2025 //
FDA
